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Abstract  
The present review study was conducted to bring the attention to 
various roles played by heat shock proteins (HSPs) in Parkinson Disease 
(PD). HSPs as chaperons play significant roles through offering cellular 
protection against multi- sources of stress. It has been suggested that HSPs 
could have a great potential to be involved as molecules for potential 
therapies in various diseases among which is PD. 
Because HSPs are involved almost in all cells, and because PD involves 
defects in brain and skeletal muscles, any improvement in cellular response 
through the reactivity of HSPs should be considered significant. We have 
also discussed the roles of various proteins included in HSPs, since they are 
varying according to their molecular weight with varying functions. 
We also aimed to bring more excitement to encourage researchers for 
conducting more studies in HSPs as targeted therapies in more details related 
to various proteins within the family of HSPs. 
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Introduction  
Heat Shock Proteins 
Heat shock proteins (HSPs) have been studied extensively in 
literature and proved to provide an intrinsic mechanism to defend the cell 
against external diverse physiological stress that may initiate a cascade of 
events affecting cell structure and function. It has been assumed that, due to 
the high conservation of HSPs throughout the evolution, these proteins may 
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have a vital role in protecting cells from injury. HSPs are composed of 
several classes of proteins according to their molecular weight, which 
include high-molecular-mass HSPs (≥100kD), HSP90 (81 to 99kD), HSP70 
(65 to 80kD), HSP60 (55 to 64kD), HSP40 (35 to 54kD) and small HSPs 
(≤34kD) (Hart, 1996).  
It has been indicated that different classes of HSPs to play a diversity 
role in governing proper protein assembly, folding, and translocation (Hart, 
1996; Hightower, 1991). Furthermore, regulation of these HSPs synthesis 
has been found to create a unique defense system to maintain cellular protein 
homeostasis and to ensure cell survival (Hightower, 1991). 
The understanding of HSPs’ function is based on two main lines of 
evidence: (1) the clearance of waste proteins requires protein folding 
machinery called chaperones (Hart, 1996), and (2) HSPs chaperones bind to 
denatured proteins to promote their degradation (Hightower, 1991). Other  
evidence suggests that HSPs may actively participate in an array of cellular 
processes, including cytoprotection (Benn, 2004) and HSPs dysfunction may 
contribute to the pathogenesis of PD, a disease characterized by 
conformational changes in proteins that result in misfolding, aggregation and 
intracellular Lewy Body formation (Meriin, 2005). 
 
HSPs and PD Pathophysiology 
Many neurodegenerative disorders, including PD, Alzheimer’s 
disease (AD), amyotrophic lateral sclerosis (ALS), Huntington disease (HD) 
and other polyglutamine expansion disorders, are associated with 
degeneration and death of specific neuronal populations due to accumulation 
of certain abnormal polypeptides or proteins (Meriin, 2005). Numerous 
studies implicate that at least two components of cellular proteins are 
associated with PD: the ubiquitin proteasomal system (UPS) and the HSPs 
(Berke, 2003; Grunblatt, 2004). Transcriptional analysis of multiple brain 
regions in PD indicates the impairment of multiple electron transport chain 
complexes and the dysfunction of UPS in PD, along with a robust induction 
of several forms of HSPs (Zhang, 2005). Inclusion bodies called Lewy 
bodies with aberrant misfolding and aggregative proteins are common 
pathological hallmark in PD, indicating that abnormality of protein 
homeostasis may contribute to the pathogenesis of the disease (McLean, 
2002). Hsp70 and Torsin A, a homology to yeast Hsp104 and mutations of 
the gene causing dystonia, are colocalized with α-synuclein (αSN) containing 
Lewy bodies. Further, Dedmon (2005) found that Hsp70 could inhibit αSN 
fibril formation through preferential binding to prefibrillar species to change 
the characteristics of toxic αSN aggregates. This work therefore elucidates a 
specific role of Hsp70 in the pathogenesis of PD and supports a general 
concept that chaperone action is a crucial aspect in protecting against the 
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otherwise damaging consequences of protein misfolding. With ageing, the 
level of HSPs is decreased insufficiently to keep the cellular proteins 
homeostasis, which may give rise to certain diseases (Meriin, 2005; Berke; 
2003).  
 
PD-Related Gene Mutations and Possible Association with HSPs 
During the last decade of discovery of several PD-associated mutant 
genes a remarkable progress has been made to help our understanding of the 
biology of PD. So far there are at least 6 genes and several loci that have 
been identified responsible to PD (Le, 2004; Moore, 2005).  It is 
hypothesized that UPS dysfunction resulted from these defected genes may 
cause protein misfolding and aggregation, and eventually lead to nigral cell 
degeneration (McNaught, 2004). Polymorphisms in the 5’ promoter regions 
of Hsp70 gene have been found significantly associated with PD (Wu, 2004). 
 
Alpha-synuclein (αSN) 
αSN, which plays a critical role in regulating synaptic vesicle size 
with particular relevance to dopamine storage, was found to be the main 
component in the Lewy body. Stress can increase the αSN protein 
aggregation and inclusion body formation (Macario, 2005); misfolding αSN 
can change proteasome composition, impair proteasome-mediated protein 
degradation, alter protein synthesis, and reduce the ability of cells to 
withstand stationary phase ageing (Chen, 2005). Three mutations of αSN, 
which show toxic gain-of-function, have been found in association with 
familial PD (Le, 2004; Moore, 2005). Inducible expression of mutant αSN in 
PC12 cell lines can result in greater sensitivity to proteasomal impairment, 
leading to mitochondrial abnormalities and neuronal cell death (Tanaka, 
2001). αSN at nanomolar concentration is able to increase Hsp70 protein 
level in PC12 cells, which can reduce αSN aggregation and toxicity 
(Kluchen, 2004). In addition, the αSN protein has a tendency to self-
aggregate and the protein level of αSN is increased in SNc with ageing 
(Cuervo, 2004).  
 
Parkin 
Parkin is a member of E3 ligase in the UPS (Shimura, 2000). Parkin 
mutations are thought to result in the improper targeting of its substrates for 
proteasomal degradation leading to potentially neurotoxic accumulation 
(Kim, 2003). Thus, great emphasis has been placed on the identification of 
substrates of parkin and their possible role in dopaminergic neuron loss in 
PD (Moore, 2005).  It has been shown that the bcl-2-associated athanogene 5 
(BAG5) can enhance dopaminergic neuron death in a vivo model of PD 
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through inhibiting the E3 ligase activity and the chaperone activity of Hsp70 
(Liu, 2002).  
 
Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) 
UCH-L1, a highly abundant and neuronal specific protein that 
belongs to a family of deubiquitinating enzymes, is responsible for 
hydrolyzing polymeric ubiquitin chains to free ubiquitin monomers (Le, 
2004; Moore, 2005). UCH-L1 might additionally act as a dimerization-
dependent ubiquitin protein ligase (Liu, 2002) and maintain ubiquitin 
homeostasis by promoting the stability of ubiquitin monomers in vivo 
(Osaka, 2003). When UCH-L1 mutates, ubiquitin recycling is reduced, 
which may lead to aggregation of aberrant proteins. It is found that UCH-L1 
aggresomes colocalize with Hsp70, chaperone BiP, and other ubiquitinated 
proteins (Ardley,  2004), suggesting that UCH-L1 may interact with HSPs in 
an attempt to participate in protein degradation. DJ-1 DJ-1 is a novel 
oncogene and mutations in this gene can cause familial PD. It is reported that 
DJ-1 mutations may result in oxidative stress and mitochondrial injury, 
which may lead to protein aggregation and neuronal cell death (Le, 2004; 
Moore, 2005). Li et al (2005) reported that DJ-1 and its mutants are 
associated with Hsp70, CHIP and mtHsp70/Grp75, a mitochondria-resident 
Hsp70; and DJ-1 and its mutants are colocalized with Hsp70 and CHIP in 
cells. Furthermore, H2O2 treatment in cells enhances DJ-1 interaction with 
mtHsp70 in mitochondria (Li, 2005). These findings suggest that 
translocation of DJ-1 to mitochondria after oxidative stress is carried out by 
chaperones. 
 
Protective Role of HSPs in PD 
It has been reported that Hsp70 is associated with αSN, dopamine 
transporter (DAT), parkin, proteasome subunits, ubiquitin and UCH-L1 
(Cuervo, 2004). Hsp70 is believed not only to protect cells from rotenone-
mediated cytotoxicity but also to decrease soluble αSN aggregation (Zhou, 
2004). Furthermore, Hsp70 can work as a putative anti-apoptotic factor to 
protect against neuronal cell death in PD (Benn, 2004; Meriin, 2005). These 
results highlight the possibility of using Hsp70 as a potential therapy for PD. 
Recent studies of function and inducer of Hsp90 also indicate its potential 
therapy for PD (Uryu, 2006; Waza, 2006).  
 
Hsp90 
Hsp90 is the main component of the cytosolic molecular chaperone 
complex that has been implicated in the negative regulation of the heat shock 
factor 1 (HSF1). HSF1 is responsible for the transcriptional activation of the 
heat shock genes including Hsp40, Hsp70, and Hsp90 (Bharadwaj, 1999), 
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suggesting a regulatory role in Hsp90 synthesis at the transcriptional level. 
Hsp90 forms a multichaperone complex with Hsp70 and Hsp40 to regulate 
several regulatory proteins, such as steroid hormone receptors (Sabbah, 
1996) and transcription factors (Zhang, 2006), and to modulate the protein 
translocation from peroxisomal to organelle (Crookes, 1998). The interplay 
between these chaperones is of crucial importance for cell function and 
survival. Recently, Uryu et al. demonstrated that Hsp90 was predominantly 
increased in PD brains, which was in correlation with the elevated level of 
insoluble αSN. These alterations of Hsp90 in PD brain were recapitulated by 
neuropathological findings in αSN mutant transgenic mouse model of PD 
(Uryu, 2006). Furthermore, exposure of cells to proteasome inhibitors 
resulted in increased levels of Hsp90 (Uryu, 2006).  
Microglia, which plays a principal role of inflammation in brain 
(Mor, 1999), express high levels of Hsp90 following excitotoxic lesion in the 
mouse hippocampus (Jeon, 2004). The protective function of Hsp90 can be 
very important since inflammation evoked by microglia may increase the 
risk of PD. Recently, we have demonstrated that (-)-Epigallocatechin gallate 
EGCG, a major monomer of green tea polyphenols, is a potent inhibitor of 
microglial activation (Li, 2004). EGCG could directly bind to Hsp90 and 
stabilize the complex of Hsp90 (Palermo, 2005).Thus EGCG could be used 
to alleviate microglia-mediated dopaminergic neuronal injury in PD. 
 
Hsp70 
Auluck et al. (2002) reported that application of Hsp70 can prevent 
dopaminergic neuronal loss in αSN transgenic Drosophila and interference 
with endogenous chaperone activity can accelerate αSN toxicity. 
Furthermore, Lewy bodies in human postmortem tissues were usually 
immunostained positive for molecular chaperones, suggesting that 
chaperones may play a role in PD progression (Auluck, 2002). It has been 
reported that Hsp70 can enhance parkin binding and ubiquitinating of 
expanded polyglutamine protein in vitro, suggesting that Hsp70 may help 
recruit misfolded proteins as substrates for parkin E3 ubiquitin ligase activity 
(Tsai, 2003). This finding provides a direct evidence to show the Hsp70 can 
promote the activity of E3 ligase to degrade aberrant αSN. 
It is postulated that Hsp70 itself or cooperating with other factors can 
protect the neurons from cytotoxicity caused by aberrant proteins. The 
crosstalk between the Hsp70 and UPS may provide a clue for the intrinsic 
mechanism of protein aggregation and degradation. Moreover, Hsp70 exerts 
anti-apoptotic activity by blocking the function of several key proapoptotic 
factors (Benn, 2004). Several studies have demonstrated that Hsp70 may 
play a role in neuroprotection against rotenone-mediated apoptosis in human 
dopaminergic cell line SH-SY5Y in vitro and against MPTP-induced nigral 
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injury in vivo by inhibiting the proapoptotic factors as well as activating the 
survival pathway (Pan, 2005; Shen, 2005). 
 
Small HSPs 
Chaperone Hsp25/27(Hsp25 in mice and Hsp27 in humans), is an 
inhibitor of actin polymerization (Miron, 1991), which has been 
demonstrated to play a major role in actin filament dynamics in diverse cell 
types (Benn, 2004). In human endothelial cells, inhibition of p38-MAPK 
activation can abolish Hsp27phosphorylation, actin polymerization, and cell 
migration (Huot, 1997). p38-MAPK may act as an upstream activator of 
stress-inducible Hsp25/27 phosphorylation. It has been demonstrated that 
Hsp27 could bind to the microtubule associated protein tau and lead to 
decreased level of hyperphosphorylated tau and therefore enhance cell 
survival in AD (Shimura, 2004). Another important function of Hsp27 is its 
protective effects on mitochondria pathway leading to inhibition of apoptosis 
(Concannon, 2003). It has been found that Hsp27 can block the tBID 
entering the mitochondria and reduce SMAC and Cytochrome C releasing 
from mitochondria so as to block the apoptotic process (Benn, 2004).  
αB-crystallin Chaperone (Hsp22): Increased expression and abnormal 
aggregation of small HSPs αB-crystallin has been detected in Lewy bodies 
and reactive astrocytes in various neurodegenerative diseases  (Yun, 2002).. 
Rekas et al (2004) demonstrated that αB-crystallin was a potent inhibitor of 
αSN fibrillization in vitro. αB-crystallin may redirect αSN from a fibril-
formation pathway towards an amorphous aggregation pathway, thus 
reducing the amount of physiologically stable amyloid deposits in favor of 
easily degradable amorphous aggregates (Rekas, et al, 2004). It has been 
reported that treatment with proteasomal inhibitors MG-132 or lactacystin in 
cultured rat brain oligodendrocytes can cause apoptotic cell death and 
induction of heat shock proteins in a time- and concentration-dependent 
manner (Goldbaum, 2004). Specifically in this study, αB-crystallin was up-
regulated, and ubiquitinated proteins were accumulated. Meanwhile, the tau 
was dephosphorylated, which enhanced its microtubule-binding capacity 
(Goldbaum, 2004). These findings imply that αB-crystallin may work 
together with other HSPs, ubiquitin and microtubule associated proteins 
(MAPs) to cope with stressed conditions. 
 
Potential Target for the Treatment of PD 
Dong et al. (2005) reported that Hsp70 gene transferred to 
dopaminergic neurons by a recombinant adeno-associated virus significantly 
protected the mouse against MPTP-induced nigral dopaminergic neuron loss 
and striatal dopamine levels decline (Dong et al, 2005). Hsp70 attenuated 
MPTP induced apoptosis in the SNpc, and increased amphetamine-induced 
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rotation (Dong et al, 2005). Collectively, these results demonstrate that 
increasing chaperone activity may be beneficial for the treatment of PD. 
HSPs may exert protective function through two major pathways besides 
their own chaperon activity: reducing mitochondrial dysfunction and 
oxidative stress, and preventing UPS impairment. 
 
Anti-apoptotic effects of HSPs in PD 
Mitochondrial dysfunction is probably the leading cause of increased 
oxidative stress and apoptosis in PD. Dopaminergic neurons are more 
vulnerable to oxidative stress than other neurons because of the special 
substrate dopamine (Jenner, 2003). In general, apoptotic process can be 
divided into the three phases: induction (or triggering), transduction of 
signal, and execution. Theoretically, HSPs may modulate any of these 
apoptotic phases to rescue the cells (Beere, 2001). In addition, it has been 
reported that stable expression of wild-type αB-crystallin protects cancer 
cells from caspase-3 activation in vitro, indicating that small HSPs αB-
crystallin is a novel inhibitor of the activation of apoptosis (Kamradt, 2005). 
Other gene products linked to monogenic forms of PD also appear to be 
implicated in mitochondrial dysfunction. Parkin can interact with leucine-
rich repeat kinase 2 (Lrrk2) which is part of the mitochondrial outer 
membrane (Smith, 2005; West, 2005). Thus, Parkin may have an unexpected 
role in the regulation of normal mitochondrial function in an indirect way 
(Palacino, 2004; Winklhofer, 2003). 
 
HSPs may promote the UPS in protein degradation 
The UPS plays a pivotal role in the degradation of short-lived 
regulatory proteins which are components of cell cycle regulation, cell 
surface receptors, ion channels modulation, and antigen presentation 
(Schwartz, 1999). It is believed that once the disposal system fails to work, 
the substances, such as regulatory molecules p53, NFκB, and Bax that 
promote apoptosis, may accumulate to a high level that is harmful to the cell 
(Hernandez, 2004). A hypothesis for the etiology of PD is that subsets of 
neurons are vulnerable to a failure in proteasome-mediated protein turnover 
(Schwartz, 1999). Accumulation of ubiquitin conjugates has been reported in 
the pathologic lesions of many chronic neurodegenerative diseases, such as 
the neurofibrillary tangles in AD and brainstem Lewy bodies in PD 
(Winklhofer, 2003; Schwartz, 1999). Inhibition of proteasome activity will 
sensitize dopaminergic neurons to protein alterations and oxidative stress 
(Mytilineou, 2004). Hsp90, together with Hsc70, Hsp40 and 20S proteasome 
subunit are the effective components to capture firefly luciferase during 
thermal inactiveness and to prevent it from undergoing an irreversible off-
pathway (Minami, 2000). The 20S proteasome has been found in tight 
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association with the molecular chaperone Hsp90 (Whittier, 2004). Composed 
within 26S proteasome subunit, they form a complex involved in a multitude 
of intracellular processes (Schwartz, 1999). In addition, Kim et  al(1999) has 
demonstrated that the inhibition of proteasome can increase the expression of 
Hsp27 and Hsp70, implying that HSPs may act as compensation of UPS or 
work together to regulate the intracellular protein level. Robertson et al. 
supported the hypothesis by demonstrating that Hsp70 antisense oligomers 
enhanced proteasome inhibitor-induced apoptosis (Robertson, 1999). 
All evidences above implicate that HSPs and UPS are participants in 
keeping proteins folding correctly. They provide an effective protein quality 
control system that is essential for cellular functions and survival in many 
tissues. Dysfunction of these systems leads to protein aggregation and 
inclusion body formation in dopaminergic neurons. 
 
HSPs inducers and their potential application in PD 
It is proposed that up-regulation of protective factors may benefit our 
cells, but overload of some proteins may be a burden for cells or even cause 
cancer. So we need to find better way to keep cells in delicate balance with 
maximal protective effects and minimal side effects. Cyclopentenone 
prostaglandin A1 (PGA1), an inducer of HSPs, has been shown to inhibit 
SH-SY5Y neuron apoptosis. PGA1 can protect against rotenone-induced 
neuronal degeneration by promoting the expression of HSPs as well as 
attenuating nuclear translocation of NF-kappaB and caspase-3 activation 
(Wang, 2002). Geldanamycin (GA) binds to an ATP site on HSP90 and 
blocks its interaction with HSF1 to promote HSF1 activation (Zou, 1998). 
GA also sensitizes the stress response within normal physiological 
parameters to enhance chaperone activation and offerprotection against αSN 
neurotoxicity (Auluck, 2005). Furthermore, GA uncouples neuronal toxicity 
from Lewy body and Lewy neurite formation so that dopaminergic neurons 
are protected from the effects of αSN expression despite the continued 
presence of or even increased inclusion pathology (Auluck, 2005). 
Significantly, GA does not alter the basal level of HSP70, suggesting that 
GA acts only to elevate chaperone levels in stressed cells and does not alter 
chaperone activity in neighboring, healthier cells (Auluck, 2005). Because  
αSN expression leads to a local elevation of inducible HSP70 in 
dopaminergic neurons (Auluck, 2002), these neurons should be preferentially 
targeted by GA treatment (Auluck, 2005). Its new derivative 17-Allylamino-
17-demethoxygeldanamycin 17-AAG shares its important biological 
activities with less toxicity (Waza et al, 2006), which gives us a much bright 
perspective to use GA to induce specific HSPs expression and to attenuate 
the side effect. 
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There is feasibility to use Hsp70 as a pretreatment therapy because 
there are many nontoxic or low toxic Hsp70 inducers available, such as 
paeoniflorin (Yan, 2004), bimoclomol (co-inducer to increase the activity) 
(Nanasi and Jednakovits, 2001; Hargitai et al., 2003), radicicol, and valproic 
acid (VPA) (Pan, 2005). These Hsp70 inducers can up-regulate Hsp70 
effectively for reconfirmation of the cellular homeostasis. Thus, it is hope 
that modulates the stress response by inducers can be a promising target for 
treatment of PD. 
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